CivicKnodeCivicKnowA project of CivicKnode
Sign in

HB 1654

Did not advance
Add to calendar

Prescription Drug Monitoring Program - Prescribers of Opioids - Notification Requirement

Sponsor: Delegate BeitzelCommittee: Rules and Executive NominationsSubject: Public HealthStatus: First Reading House Rules and Executive Nominations (as of Nov 6, 2020)

What this bill does

Official synopsis

Requiring a prescriber to notify the Prescription Drug Monitoring Program as to whether the prescriber has received education regarding the risks of opioid use, is aware that an opioid overdose reversal drug is available, and has prescribed or dispensed an opioid overdose reversal drug if the prescriber prescribes or dispenses an opioid in a dosage of 50 morphine milligram equivalents or more; and prohibiting a prescriber from being required to make a certain notification more than once.

AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.

Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.

Testimony (0)

MGA witness list
No witness list on file because no hearing has been scheduled.